ArticleClinical trials (London, England)2020

Adaptive dose-finding based on safety and feasibility in early-phase clinical trials of adoptive cell immunotherapy.

Nolan A Wages et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.